⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for vhl gene inactivation

Every month we try and update this database with for vhl gene inactivation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell CarcinomaNCT03108066
VHL Gene Mutati...
VHL
VHL Syndrome
VHL Gene Inacti...
Von Hippel
Von Hippel-Lind...
Von Hippel's Di...
Von Hippel-Lind...
Clear Cell Rena...
Clear Cell RCC
ccRCC
PT2385 Tablets
18 Years - Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)NCT03401788
VHL - Von Hippe...
VHL Gene Mutati...
VHL Syndrome
VHL Gene Inacti...
VHL-Associated ...
VHL-Associated ...
Belzutifan
18 Years - Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: